• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌组织学分类中的观察者差异。

Observer variation in histologic classification of thyroid cancer.

作者信息

Saxén E, Franssila K, Bjarnason O, Normann T, Ringertz N

出版信息

Acta Pathol Microbiol Scand A. 1978 Nov;86A(6):483-6. doi: 10.1111/j.1699-0463.1978.tb02073.x.

DOI:10.1111/j.1699-0463.1978.tb02073.x
PMID:716909
Abstract

Histologic slides of 696 cases of thyroid cancer reported to the national cancer registries of Finland, Iceland, Norway and Sweden were reviewed by 5 Nordic pathologists in order to determine the observer variation between the pathologists, as well as the reproducibility of the WHO classification of thyroid tumours. In 58% of the cases all observers agreed upon the diagnosis and in 82% at least three of them agreed. The observer disagreement was lowest for papillary carcinoma (7%) and highest for follicular carcinoma (27%). The corresponding figures for anaplastic and medullary carcinomas were 18% and 23%, respectively. The most common diverging diagnosis for cases finally interpreted as papillary carcinoma was follicular carcinoma, and for cases finally interpreted as follicular carcinoma, a benign thyroid lesion. The results of the present study clearly indicate the necessity of having all cases reviewed by the same pathologist or group of pathologists in order to obtain reliable results for comparative studies.

摘要

芬兰、冰岛、挪威和瑞典国家癌症登记处报告的696例甲状腺癌组织学切片由5名北欧病理学家进行了复查,以确定病理学家之间的观察者差异,以及世界卫生组织甲状腺肿瘤分类的可重复性。在58%的病例中,所有观察者对诊断意见一致,在82%的病例中至少有三人意见一致。观察者分歧在乳头状癌中最低(7%),在滤泡状癌中最高(27%)。间变性癌和髓样癌的相应数字分别为18%和23%。最终被诊断为乳头状癌的病例最常见的不同诊断是滤泡状癌,而最终被诊断为滤泡状癌的病例,最常见的不同诊断是良性甲状腺病变。本研究结果清楚地表明,为了获得可靠的比较研究结果,所有病例必须由同一位病理学家或一组病理学家进行复查。

相似文献

1
Observer variation in histologic classification of thyroid cancer.甲状腺癌组织学分类中的观察者差异。
Acta Pathol Microbiol Scand A. 1978 Nov;86A(6):483-6. doi: 10.1111/j.1699-0463.1978.tb02073.x.
2
Incidence of different morphological types of thyroid cancer in the Nordic countries.北欧国家甲状腺癌不同形态类型的发病率。
Acta Pathol Microbiol Scand A. 1981 Jan;89(1):49-55. doi: 10.1111/j.1699-0463.1981.tb00186.x.
3
Thyroid cancer in Iceland 1955-1984.1955年至1984年冰岛的甲状腺癌
Acta Endocrinol (Copenh). 1988 Aug;118(4):566-72. doi: 10.1530/acta.0.1180566.
4
Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?甲状腺滤泡癌高细胞型病理报告:我们是否达成共识?
Thyroid. 2017 Dec;27(12):1498-1504. doi: 10.1089/thy.2017.0280. Epub 2017 Nov 7.
5
[Differentiated thyroid cancer. Their peculiarities in typing and assessment of invasiveness].[分化型甲状腺癌。其在分型及侵袭性评估方面的特点]
Zentralbl Chir. 1990;115(1):15-22.
6
Histological and functional correlation of thyroid carcinoma by immunohistochemistry.
Indian J Pathol Microbiol. 1990 Jan;33(1):35-40.
7
Histological validation of diagnoses of thyroid cancer among adults in the registries of Belarus and the Ukraine.白俄罗斯和乌克兰登记处成年甲状腺癌诊断的组织学验证。
Br J Cancer. 2003 Dec 1;89(11):2098-103. doi: 10.1038/sj.bjc.6601395.
8
Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.当审阅来自不同机构的玻片时,使用贝塞斯达系统报告甲状腺细胞学检查结果,对意义不明确的非典型性病变/意义不明确的滤泡性病变类别进行再现性研究:细胞病理学家间的观察者间变异性研究
Diagn Cytopathol. 2017 May;45(5):399-405. doi: 10.1002/dc.23681. Epub 2017 Feb 20.
9
A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].一份关于1985年至1995年在美国治疗的53856例甲状腺癌病例的国家癌症数据库报告[见评论]。
Cancer. 1998 Dec 15;83(12):2638-48. doi: 10.1002/(sici)1097-0142(19981215)83:12<2638::aid-cncr31>3.0.co;2-1.
10
Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland.甲状腺内间变性癌、滤泡状癌和乳头状癌与滤泡性腺瘤同时发生。
Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):414-5; author reply 415. doi: 10.4103/0377-4929.81600.

引用本文的文献

1
Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer.修正主义历史揭示了一种基于分子的分化型甲状腺癌简化分类。
J Pathol. 2025 Oct;267(2):130-141. doi: 10.1002/path.6456. Epub 2025 Aug 5.
2
Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid.钙黏蛋白 16(CDH16)免疫组化:用于诊断肾细胞癌和甲状腺乳头状癌的有用工具。
Sci Rep. 2023 Aug 9;13(1):12917. doi: 10.1038/s41598-023-39945-2.
3
HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.
具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)与其他滤泡型甲状腺病变中HBME1和CK19的表达情况
World J Surg Oncol. 2021 May 8;19(1):143. doi: 10.1186/s12957-021-02258-7.
4
Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign?重新命名甲状腺乳头状癌包裹性滤泡亚型的临床安全性:NIFTP真的是良性的吗?
World J Surg. 2018 Feb;42(2):321-326. doi: 10.1007/s00268-017-4182-5.
5
Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.碘摄入作为甲状腺癌的一个风险因素:对动物和人体研究的全面综述。
Thyroid Res. 2015 Jun 18;8:8. doi: 10.1186/s13044-015-0020-8. eCollection 2015.
6
Absent CD56 expression in papillary thyroid carcinoma: A finding of potential diagnostic value in problematic cases of thyroid pathology.甲状腺乳头状癌中CD56表达缺失:甲状腺病理疑难病例中一项具有潜在诊断价值的发现。
J Res Med Sci. 2013 Dec;18(12):1046-50.
7
Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.基于基因表达谱的福尔马林固定石蜡包埋组织在滤泡性甲状腺癌和腺瘤的分子鉴别诊断中的应用。
BMC Med Genomics. 2013 Oct 7;6:38. doi: 10.1186/1755-8794-6-38.
8
Molecular detection of PPAR gamma rearrangements and thyroid carcinoma in preoperative fine-needle aspiration biopsies.术前细针穿刺活检中PPARγ重排与甲状腺癌的分子检测
Endocr Pathol. 2008 Fall;19(3):166-74. doi: 10.1007/s12022-008-9036-0.
9
Do benign thyroid nodules have malignant potential? An evidence-based review.良性甲状腺结节有恶变潜能吗?一项循证综述。
World J Surg. 2008 Jul;32(7):1237-46. doi: 10.1007/s00268-008-9484-1.
10
Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules.半乳糖凝集素-3、人鼠杂交瘤单克隆抗体-1、细胞角蛋白19、高分子量细胞角蛋白、细胞周期蛋白D1和p27(kip1)在甲状腺结节鉴别诊断中的诊断价值
J Korean Med Sci. 2007 Aug;22(4):621-8. doi: 10.3346/jkms.2007.22.4.621.